Unraveling ERBB network dynamics upon betacellulin signaling in pancreatic ductal adenocarcinoma in mice

Unraveling ERBB network dynamics upon betacellulin signaling in pancreatic ductal adenocarcinoma in mice

Pancreatic ductal adenocarcinoma (PDAC) will soon belong to the top three cancer killers. The only approved specific PDAC therapy targets the epidermal growth factor receptor (EGFR). Although EGFR is a crucial player in PDAC development, EGFR‐based therapy is disappointing. In this study, we evaluat...

Full description

Bibliographic Details
Main Authors:	Kathrin Hedegger, Hana Algül, Marina Lesina, Andreas Blutke, Roland M. Schmid, Marlon R. Schneider, Maik Dahlhoff
Format:	Article
Language:	English
Published:	Wiley 2020-08-01
Series:	Molecular Oncology
Subjects:	BTC EGFR ERBB2 ERBB4 mouse model PDAC
Online Access:	https://doi.org/10.1002/1878-0261.12699

Similar Items

Trapping all ERBB ligands decreases pancreatic lesions in a murine model of pancreatic ductal adenocarcinoma
by: Kathrin Hedegger, et al.
Published: (2023-11-01)

ERBB family fusions are recurrent and actionable oncogenic targets across cancer types
by: Laura Schubert, et al.
Published: (2023-04-01)

Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer
by: Andrew J. Weickhardt, et al.
Published: (2022-05-01)

Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response
by: Jacqueline F. Donoghue, et al.
Published: (2018-07-01)

Inhibition of ERBB2-overexpressing Tumors by Recombinant Human Prolidase and Its Enzymatically Inactive Mutant
by: Lu Yang, et al.
Published: (2015-05-01)

Combining RANK/RANKL and ERBB-2 targeting as a novel strategy in ERBB-2-positive breast carcinomas
by: Ilianna Zoi, et al.
Published: (2019-12-01)

Betacellulin-Induced α-Cell Proliferation Is Mediated by ErbB3 and ErbB4, and May Contribute to β-Cell Regeneration
by: Young-Sun Lee, et al.
Published: (2021-01-01)

The transmembrane protein LRIG1 triggers melanocytic tumor development following chemically induced skin carcinogenesis
by: Christine Hoesl, et al.
Published: (2021-08-01)

Ligand-Independent EGFR Activation by Anchorage-Stimulated Src Promotes Cancer Cell Proliferation and Cetuximab Resistance via ErbB3 Phosphorylation
by: Masami Nozaki, et al.
Published: (2019-10-01)

ERBB1/EGFR and JAK3 Tyrosine Kinases as Potential Therapeutic Targets in High-Risk Multiple Myeloma
by: Fatih M. Uckun, et al.
Published: (2022-10-01)

Expression of HER2/c-erbB-2, EGFR protein in gastric carcinoma and its clinical significance
by: Cheng Guoxiong, et al.
Published: (2019-05-01)

ErbB polymorphisms: Insights and implications for response to targeted cancer therapeutics
by: Moulay A Alaoui-Jamali, et al.
Published: (2015-02-01)

Poor Efficacy of Immune Checkpoint Inhibitors Plus Chemotherapy in Lung Cancer Patients with EGFR/ERBB2 Exon 20 Insertion
by: Yue Zheng, et al.
Published: (2023-11-01)

Melatonin upregulates ErbB1 and ErbB4, two primary implantation receptors, in pre-implantation mouse embryos
by: Ghazaleh Moshkdanian, et al.
Published: (2017-06-01)

Expanding the Disorder-Function Paradigm in the C-Terminal Tails of Erbbs
by: Louise Pinet, et al.
Published: (2021-11-01)

Schizophrenia is not associated with the ERBB3 gene in a Han Chinese population sample: results from case-control and family-based studies
by: Dawei Li, et al.
Published: (2009-01-01)

ERBB1- and ERBB2-Positive Medullary Thyroid Carcinoma: A Case Report
by: Michele Minuto, et al.
Published: (2018-04-01)

Upregulated Expression of ERBB2/HER2 in Multiple Myeloma as a Predictor of Poor Survival Outcomes
by: Fatih M. Uckun, et al.
Published: (2023-06-01)

NGR4 and ERBB4 as Promising Diagnostic and Therapeutic Targets for Metabolic Disorders
by: Maria Vulf, et al.
Published: (2023-06-01)

GPAA1 promotes gastric cancer progression via upregulation of GPI-anchored protein and enhancement of ERBB signalling pathway
by: Xiao-Xin Zhang, et al.
Published: (2019-05-01)

EGFR and ERBB2 exon 20 insertion/duplication in advanced non–small cell lung cancer: genomic profiling and clinicopathologic features
by: Ramakrishna R. Sompallae, et al.
Published: (2023-05-01)

Correlative Fluorescence- and Electron Microscopy of Whole Breast Cancer Cells Reveals Different Distribution of ErbB2 Dependent on Underlying Actin
by: Indra Navina Dahmke, et al.
Published: (2020-06-01)

Cytotoxic Effects of the Dual ErbB Tyrosine Kinase Inhibitor, Lapatinib, on Walker 256 Rat Breast Tumour and IEC-6 Rat Normal Small Intestinal Cell Lines
by: Wan Nor I′zzah Wan Mohamad Zain, et al.
Published: (2019-12-01)

Análise da expressão imuno-histoquímica de c-erbB-2 e EGFR em carcinoma epidermóide de esôfago Immunohistochemical expression of c-erbB-2 and EGFR in esophageal squamous cell carcinoma
by: Yukie Sato, et al.
Published: (2007-08-01)

Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma
by: Thomasson Marcus, et al.
Published: (2012-05-01)

NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells
by: Carmen Miano, et al.
Published: (2022-03-01)

ERBB2‐amplified lobular breast carcinoma exhibits concomitant CDK12 co‐amplification associated with poor prognostic features
by: Miriam Forster‐Sack, et al.
Published: (2024-03-01)

Expression and function of Neuregulin 1 and its signaling system ERBB2/3 in the enteric nervous system
by: Martina eBarrenschee, et al.
Published: (2015-09-01)

Progress in the Research and Targeted Therapy of ErbB/HER Receptors in Urothelial Bladder Cancer
by: Dong Chen, et al.
Published: (2021-12-01)

Investigation of the prevalence and clinical implications of ERBB2 exon 16 skipping mutations in Chinese pan-cancer patients
by: Yanhong Shang, et al.
Published: (2023-01-01)

Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans
by: Marco Macagno, et al.
Published: (2011-08-01)

ErbB3 drives mammary epithelial survival and differentiation during pregnancy and lactation
by: Michelle M. Williams, et al.
Published: (2017-09-01)

ErbB4 in the brain: Focus on high grade glioma
by: Jamie-Lee Pitcher, et al.
Published: (2022-08-01)

Does EGFR Signaling Mediate Orexin System Activity in Sleep Initiation?
by: Marina Kniazkina, et al.
Published: (2023-05-01)

The lysosome as a novel therapeutic target of EGFR-mediated tumor inflammation
by: Woo Jung Sung, et al.
Published: (2022-11-01)

Epidermal Growth Factor Pathway in the Age-Related Decline of Oligodendrocyte Regeneration
by: Andrea D. Rivera, et al.
Published: (2022-03-01)

High Frequency of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with Pleomorphic Features
by: Juan Manuel Rosa-Rosa, et al.
Published: (2019-01-01)

Analysis of Somatic Mutations in Cancer: Molecular Mechanisms of Activation in the ErbB Family of Receptor Tyrosine Kinases
by: Andrew J. Shih, et al.
Published: (2011-03-01)

Erbb4 Is Required for Cerebellar Development and Malignant Phenotype of Medulloblastoma
by: Juncal Aldaregia, et al.
Published: (2020-04-01)

Role of C-erbB2 expression in gallbladder cancer
by: Niraj Kumari, et al.
Published: (2012-01-01)